跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONE GENPAR AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
MOMETASONE GENPAR AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Approved
STANDARD
MOMETASONE GENPAR AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
53431fa619f65ddd
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
53431fa619f65ddd
Product Name
MOMETASONE GENPAR AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Artg Id
233573
Artg Name
MOMETASONE GENPAR AQUEOUS NASAL SPRAY mometasone furoate 50 microgram/actuation (as monohydrate) suspension spray bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2016-01-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
53431fa619f65ddd
Type
Standard
Back to TGA Approvals
